1. Home
  2. ARWR vs VIAV Comparison

ARWR vs VIAV Comparison

Compare ARWR & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • VIAV
  • Stock Information
  • Founded
  • ARWR 2003
  • VIAV 1923
  • Country
  • ARWR United States
  • VIAV United States
  • Employees
  • ARWR N/A
  • VIAV N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • VIAV Semiconductors
  • Sector
  • ARWR Health Care
  • VIAV Technology
  • Exchange
  • ARWR Nasdaq
  • VIAV Nasdaq
  • Market Cap
  • ARWR 1.7B
  • VIAV 2.2B
  • IPO Year
  • ARWR 1993
  • VIAV 1993
  • Fundamental
  • Price
  • ARWR $12.74
  • VIAV $11.19
  • Analyst Decision
  • ARWR Buy
  • VIAV Buy
  • Analyst Count
  • ARWR 11
  • VIAV 9
  • Target Price
  • ARWR $41.44
  • VIAV $13.19
  • AVG Volume (30 Days)
  • ARWR 1.6M
  • VIAV 1.8M
  • Earning Date
  • ARWR 05-08-2025
  • VIAV 05-01-2025
  • Dividend Yield
  • ARWR N/A
  • VIAV N/A
  • EPS Growth
  • ARWR N/A
  • VIAV N/A
  • EPS
  • ARWR N/A
  • VIAV N/A
  • Revenue
  • ARWR $2,500,000.00
  • VIAV $1,007,000,000.00
  • Revenue This Year
  • ARWR $4,380.43
  • VIAV $10.56
  • Revenue Next Year
  • ARWR $58.72
  • VIAV $7.78
  • P/E Ratio
  • ARWR N/A
  • VIAV N/A
  • Revenue Growth
  • ARWR N/A
  • VIAV N/A
  • 52 Week Low
  • ARWR $12.20
  • VIAV $6.60
  • 52 Week High
  • ARWR $30.41
  • VIAV $12.91
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 27.27
  • VIAV 47.20
  • Support Level
  • ARWR $14.69
  • VIAV $10.63
  • Resistance Level
  • ARWR $15.65
  • VIAV $12.06
  • Average True Range (ATR)
  • ARWR 0.78
  • VIAV 0.29
  • MACD
  • ARWR -0.12
  • VIAV 0.01
  • Stochastic Oscillator
  • ARWR 13.07
  • VIAV 39.16

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: